Thus, we found a weak tendency towards a higher SEC62 expression and a significantly lower SOX2 expression in the lymph node metastases from CUP patients compared with the HNSCC patients (Figure 3A). The gene discussed is SEC62; the disease is head and neck squamous cell carcinoma.